![](/img/cover-not-exists.png)
Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective
Doral Stefani, Stephen, Giorgio Saggia, Mario, Vicino dos Santos, Eduardo AugustusVolume:
11
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696990802208186
Date:
September, 2008
File:
PDF, 614 KB
english, 2008